NANP and malaria: Two WHO-approved malaria vaccines - RTS,S/AS01E5 and R21/Matrix-M6 – display a truncated fragment of PfCSP compromised of 19 NANP repeats and the C-terminal region expressed with the hepatitis B surface antigen virus-like particle (HBsAg VLP).